Quantitative online prediction of peptide binding to the major histocompatibility complex

Journal of Molecular Graphics and Modelling

Volumn 22, Issue 3, 2004, Pages 195-207

  Hattotuwagama, Channa K ^a   Guan, Pingping ^a   Doytchinova, Irini A ^a   Zygouri, Christianna ^a   Flower, Darren R ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

Major histocompatibility complex; Partial least squares; Peptide binding; Quantitative structure activity relationships; T cell epitope

Indexed keywords

ANTIGENS; SERVERS; VACCINES;

MAJOR HISTOCOMPATIBILITY COMPLEX (MHC);

PROTEINS;

ANTIGEN PRESENTATION; ARTICLE; IMMUNOBIOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIVARIATE ANALYSIS; ONLINE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

EID: 0242391296     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1093-3263(03)00160-8     Document Type: Article

References (38)

1. Holtappels R., Grzimek N.K., Thomas D., Reddehase M.J. Early gene m18, a novel player in the immune response to murine cytomegalovirus. J. Gen. Virol. 83:2002;311-316.
2. Holtappels R., Thomas D., Podlech J., Reddehase M.J. Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J. Virol. 76:2002;151-164.
3. Pellequer J.L., Westhof E. PREDITOP, a program for antigenicity prediction. J. Mol. Graph. 11:1993;204-210.
4. Alix A.J. Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine. 18:1999;311-314.
5. Thornton J.M., Edwards M.S., Taylor W.R., Barlow D.J. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J. 5:1986;409-413.
6. D.R. Flower, I.A. Doytchinova, K. Paine, P. Taylor, M.J. Blythe, D. Lamponi, C. Zygouri, P. Guan, H. McSparron, H. Kirkbride, Computational vaccine design, in: D.R. Flower (Ed.), Drug Design, Cutting Edge Approaches, RSC Publications, London, 2002.
7. Doytchinova I.A., Blythe M.J., Flower D.R. An additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J. Proteome Res. 1:2002;263-272.
8. Blythe M.J., Doytchinova I.A., Flower D.R. JenPep, a database of quantitative functional peptide data for immunology. Bioinformatics. 18:2002;434-439.
9. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
10. SYBYL 6.7. Tripos Inc., 1699 Hanley Road, St. Louis, MO 63144.
11. Bush B.L., Nachbar R.B. Jr. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J. Comput. Aided Mol. Des. 7:1993;587-619.
12. Menssen R., Orth P., Ziegler A., Saenger W. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J. Mol. Biol. 285:1999;645-653.
13. Smith K.J., Reid S.W., Stuart D.I., McMichael A.J., Jones E.Y., Bell J.I. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity. 4:1996;203-213.
14. Sinigaglia F., Hammer J. Motifs and supermotifs for MHC class II binding peptides. J. Exp. Med. 181:1995;449-451.
15. Guan P., Doytchinova I.A., Flower D.R. HLA-A3-supermotif defined by quantitative structure-activity relationship analysis. Prot Eng. 16:2003;11-18.
16. Doytchinova I.A., Flower D.R. The HLA-A2-supermotif: A QSAR definition. J. Comp. Biol. 1:2003;2648-2654.
17. Sette A., Buus S., Appella E., Smith J.A., Chesnut R., Miles C., Colon S.M., Grey H.M. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3296-3300.
18. Takamiya Y., Schonbach C., Nokihara K., Yamaguchi M., Ferrone S., Kano K., Egawa K., Takiguchi M. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int. Immunol. 6:1994;255-261.
19. Sidney J., del Guercio M.F., Southwood S., Engelhard V.H., Appella E., Rammensee H.G., Falk K., Rotzschke O., Takiguchi M., Kubo R.T. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:1995;247-259.
20. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 50:1999;213-219.
21. D'Amaro J., Houbiers J.G., Drijfhout J.W., Brandt R.M., Schipper R., Bavinck J.N., Melief C.J., Kast W.M. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum. Immunol. 43:1995;13-18.
22. Ruppert J., Sidney J., Celis E., Kubo R.T., Grey H.M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:1994;929-934.
23. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Kast W.M., Melief C.J., Oseroff C., Yuan L., Ruppert J. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:1994;5586-5592.
24. Parker K.C., Bednarek M.A., Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side chains. J. Immunol. 152:1994;163-175.
25. M.T. Swain, A.J. Brooks, G.J.L. Kemp, An automated approach to modelling class II MHC alleles and predicting peptide binding, in: Proceedings of the Second IEEE International Symposium on Bio-Informatics and Biomedical Engineering, IEEE Computer Society Press, in press.
26. Fleckenstein B., von der Mulbe F., Wessels J., Niethammer D., Wiesmuller K.H. From combinatorial libraries to MHC ligand motifs, T-cell superagonists and antagonists. Jung G. Biologicals. 29:2001;179-181.
27. Touloukian C.E., Leitner W.W., Topalian S.L., Li Y.F., Robbins P.F., Rosenberg S.A., Restifo N.P. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164:2000;3535-3542.
28. Singh H., Raghava G.P. ProPred, prediction of HLA-DR binding sites. Bioinformatics. 17:2001;1236-1237.
29. Tangri S., Ishioka G.Y., Huang X., Sidney J., Southwood S., Fikes J., Sette A. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J. Exp. Med. 194:2001;833-846.
30. Hellberg S., Sjostrom M., Skagerberg B., Wold S. Peptide quantitative structure-activity relationships, a multivariate approach. J. Med. Chem. 30:1987;1126-1135.
31. Sandberg M., Eriksson L., Jonsson J., Sjostrom M., Wold S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J. Med. Chem. 41:1998;2481-2491.
32. Golbraikh A., Tropsha A. Beware of q2. J. Mol. Graph Model. 20:2002;269-276.
33. Doytchinova I.A., Flower D.R. Toward the quantitative prediction of T-cell epitopes, CoMFA and CoMSIA studies of peptides with affinity for the Class I MHC molecule HLA-A*0201. J. Med. Chem. 44:2001;3572-3581.
34. Doytchiniva I.A., Flower D.R. Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex. A three-dimensional quantitative structure-activity relationship study. Proteins. 48:2002;505-518.
35. Doolan D.L., Hoffman S.L., Southwood S., Wentworth P.A., Sidney J., Chesnut R.W., Keogh E., Appella E., Nutman T.B., Lal A.A., Gordon D.M., Oloo A., Sette A. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity. 7:1997;97-112.
36. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:1997;503-513.
37. Sidney J., del Guercio M.F., Southwood S., Engelhard V.H., Appella E., Rammensee H.G., Falk K., Rotzschke O., Takiguchi M., Kubo R.T., et al. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:1995;247-259.
38. Sidney J., Southwood S., del Guercio M.F., Grey H.M., Chesnut R.W., Kubo R.T., Sette A. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:1996;3480-3490.